These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 350144)
1. [Bioavailability of tetracycline hydrochloride capsules (an in vivo study)]. Zak AF; Ermolova OB; Batuashvili TA; Minasova GS; Nesterova LIa Antibiotiki; 1978 May; 23(5):441-5. PubMed ID: 350144 [TBL] [Abstract][Full Text] [Related]
2. [Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study)]. Grakovskaia LK; Nesterova LIa; Okhotnikova VF; Zak AF; Ermolova OB Antibiotiki; 1978 Mar; 23(3):215-9. PubMed ID: 637528 [TBL] [Abstract][Full Text] [Related]
3. [Bioavailability of drug forms of tetracycline-group semisynthetic preparations for internal use]. Zak AF; Batuashvili TA Antibiotiki; 1983 Sep; 28(9):659-63. PubMed ID: 6638980 [TBL] [Abstract][Full Text] [Related]
4. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic]. Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252 [TBL] [Abstract][Full Text] [Related]
5. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals]. Zak AF; Ermolova OB Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466 [TBL] [Abstract][Full Text] [Related]
6. [Effect of the crystallization conditions of tetracycline base on the properties of the powders and drug forms obtained. The dependence of the degree of dispersion of tetracycline base on the crystallization conditions]. Lin'kov GI; Zhukovskaia SA; Dzhabarov DN; Nabokov VS Antibiotiki; 1977 Sep; 22(9):841-6. PubMed ID: 20836 [TBL] [Abstract][Full Text] [Related]
7. [Bioavailability of peroral antibiotic preparations]. Zak AF Antibiotiki; 1977 Mar; 22(3):265-79. PubMed ID: 322606 [No Abstract] [Full Text] [Related]
8. [Bioavailability of peroral drug forms of oxacillin]. Batuashvili TA; Shchedrin VI; Zak AF Antibiotiki; 1979 Aug; 24(8):611-5. PubMed ID: 485110 [TBL] [Abstract][Full Text] [Related]
9. [Effect of the tetracycline base crystallization conditions on the properties of the powders and drug forms obtained. Relationship between the dispersity of the tetracycline powder and the biological availability in capsules]. Lin'kov GI; Okhotnikova VF; Koroleva VG; Nabokov VS; Zhuskovskaia SA Antibiotiki; 1978 Feb; 23(2):174-8. PubMed ID: 629528 [No Abstract] [Full Text] [Related]
11. [Properties of tetracycline hydrochloride tablets and their bioavailability]. Zak AF; Batuashvili TA; Loseva GI; Shatrova VM; Ermolova OB Antibiotiki; 1980 Mar; 25(3):179-84. PubMed ID: 7362222 [TBL] [Abstract][Full Text] [Related]
12. [Bioavailability of levomycetin preparations for oral use]. Batuashvili TA; Zak AF Antibiotiki; 1983 Oct; 28(10):751-4. PubMed ID: 6651263 [TBL] [Abstract][Full Text] [Related]
13. Effect of some additives on the properties of phenazopyridine hydrochloride granules and their corresponding tablets. el-Sabbagh HM; Meshali M; Ghanem A; Abdel-Aleem H Pharmazie; 1984 Jun; 39(6):404-6. PubMed ID: 6483945 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine. Tuncel T; Bergsadi N; Akin L; Otük G; Kuşçu I Pharmazie; 1996 Mar; 51(3):168-71. PubMed ID: 8900867 [TBL] [Abstract][Full Text] [Related]
15. Effect of magnesium trisilicate and citric acid on the biovailability of tetracycline in man. Khalil SA; Daabis NA; Naggar VF; Wafik M Pharmazie; 1977; 32(8-9):519-22. PubMed ID: 201941 [TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride. Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251 [TBL] [Abstract][Full Text] [Related]
17. [Effect of tetracycline base crystallization on the conditions properties of the powders and drug forms obtained. The development of directed crystallization procedures for tetracycline base]. Lin'kov GI; Zhukovskaia SA Antibiotiki; 1977 Aug; 22(8):678-83. PubMed ID: 20834 [TBL] [Abstract][Full Text] [Related]
18. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of ranitidine hydrochloride loaded hollow microspheres in rabbits. Wei YM; Zhao L Arch Pharm Res; 2008 Oct; 31(10):1369-77. PubMed ID: 18958430 [TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of methacycline hydrochloride capsules and tablets according to their dissolubility and rate of solution]. Berezovskaia LN; Grakovskaia LK; Nesterova LIa Antibiotiki; 1979 Aug; 24(8):604-8. PubMed ID: 485108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]